ES2178651T3 - Compuestos carotenoides terapeuticos deispersables en agua. - Google Patents

Compuestos carotenoides terapeuticos deispersables en agua.

Info

Publication number
ES2178651T3
ES2178651T3 ES94911015T ES94911015T ES2178651T3 ES 2178651 T3 ES2178651 T3 ES 2178651T3 ES 94911015 T ES94911015 T ES 94911015T ES 94911015 T ES94911015 T ES 94911015T ES 2178651 T3 ES2178651 T3 ES 2178651T3
Authority
ES
Spain
Prior art keywords
pct
deispersable
therapeutic
water
carotenoid compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94911015T
Other languages
English (en)
Inventor
Lance Elliott Schlipalius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Australia Pty Ltd
Original Assignee
Cognis Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Australia Pty Ltd filed Critical Cognis Australia Pty Ltd
Application granted granted Critical
Publication of ES2178651T3 publication Critical patent/ES2178651T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA UN AGENTE TERAPEUTICO PARA SU ADMINISTRACION MEDIANTE INYECCION O DE FORMA INTRAVENOSA QUE INCLUYE LA MECLA DE: A) UN COMPONENTE DISPERSIBLE O SOLUBLE EN AGUA; B) UN COMPONENTE EMULSIFICANTE; Y C) UN AGENTE TERAPEUTICO INSOLUBLE EN AGUA EN UN MEDIO PORTADOR ADECUADO.
ES94911015T 1993-03-22 1994-03-22 Compuestos carotenoides terapeuticos deispersables en agua. Expired - Lifetime ES2178651T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL793593 1993-03-22

Publications (1)

Publication Number Publication Date
ES2178651T3 true ES2178651T3 (es) 2003-01-01

Family

ID=3776794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94911015T Expired - Lifetime ES2178651T3 (es) 1993-03-22 1994-03-22 Compuestos carotenoides terapeuticos deispersables en agua.

Country Status (8)

Country Link
US (1) US5773026A (es)
EP (1) EP0689427B1 (es)
JP (1) JPH08510995A (es)
AT (1) ATE218855T1 (es)
AU (1) AU696956B2 (es)
DE (1) DE69430799T2 (es)
ES (1) ES2178651T3 (es)
WO (1) WO1994021232A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980703596A (ko) * 1990-10-01 1998-12-05 쉘비 캘버트 모스 주요 혈관 이상 상태를 억제하기 위한 베타-카로틴 및 비타민 e 치료법
US6132790A (en) * 1991-09-06 2000-10-17 Betatene Limited Carotenoid composition
AU700249B2 (en) * 1994-04-08 1998-12-24 Cognis Australia Pty Ltd Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
AUPM493194A0 (en) * 1994-04-08 1994-05-05 Buckmeier, Julie A. Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
WO1995031956A1 (en) * 1994-05-20 1995-11-30 Novavax, Inc. Antibacterial oil-in-water emulsions
DE19609476A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
AU5806998A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
WO1998045241A2 (en) 1997-04-04 1998-10-15 Henkel Corporation Lutein esters having high bioavailability
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US6767342B1 (en) 2001-04-23 2004-07-27 Evelyna D. Cantwell Oxygen bandage system
US7145025B2 (en) * 2002-07-29 2006-12-05 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
GB0523431D0 (en) * 2005-11-17 2005-12-28 Inst For Akvakulturforskning A Method
JP5591916B2 (ja) 2009-05-07 2014-09-17 ハンツマン・コーポレーシヨン・オーストラリア・ピーテイワイ・リミテツド 高電解質溶液中の分散剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
AU595824B2 (en) * 1985-08-30 1990-04-12 Betatene Limited Narurally-derived carotene/oil composition and the process for the production thereof by direct extraction of carotene from algae
EP0397774A1 (en) * 1988-02-04 1990-11-22 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
JPH0225418A (ja) * 1988-07-14 1990-01-26 Kyorin Pharmaceut Co Ltd イブジラスト脂肪乳剤およびその製造方法
DE3903056A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
KR19980703596A (ko) * 1990-10-01 1998-12-05 쉘비 캘버트 모스 주요 혈관 이상 상태를 억제하기 위한 베타-카로틴 및 비타민 e 치료법
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
US5298246A (en) * 1991-01-09 1994-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Stable pharmaceutical composition and method for its production
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
EP0602137B1 (en) * 1991-09-06 2002-01-23 Cognis Australia Pty Ltd Carotenoid composition
WO1993013751A1 (en) * 1992-01-16 1993-07-22 Board Of Regents, The University Of Texas System Formulation and use of carotenoids in treatment of cancer
EP0643692B1 (en) * 1992-06-04 1999-11-24 Betatene Pty. Ltd. High cis beta-carotene composition

Also Published As

Publication number Publication date
AU6370594A (en) 1994-10-11
JPH08510995A (ja) 1996-11-19
DE69430799T2 (de) 2003-02-13
AU696956B2 (en) 1998-09-24
ATE218855T1 (de) 2002-06-15
US5773026A (en) 1998-06-30
WO1994021232A1 (en) 1994-09-29
EP0689427A4 (en) 1998-04-15
EP0689427A1 (en) 1996-01-03
EP0689427B1 (en) 2002-06-12
DE69430799D1 (de) 2002-07-18

Similar Documents

Publication Publication Date Title
DE69430799D1 (de) Wasserdispersible therapeutische carotenoid verbindungen
FI971412A0 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
DE69531457D1 (en) Sulfonamide
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
SG55184A1 (en) New imidazopyridines
GB9514473D0 (en) Chemical compounds
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
GR3033828T3 (en) Substituted biphenyl compounds for the treatment of inflammation
IL129768A0 (en) Antithrombotic organic nitrates
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
HUT76553A (en) Use of gel formulations as dressing agents
PL330908A1 (en) Inhibitors of prenyl transferases
KR960700217A (ko) 액체 페놀성 산화방지제
GB9206768D0 (en) New compounds for use in the treatment of cancer
ES2145772T3 (es) Uso de un complejo de ibuprofeno-beta-ciclodextrina para administracion oral.
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
AUPM493194A0 (en) Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
ZA938414B (en) Substituted ortho-ethenylphenylacetic acid derivatives
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
ID16479A (id) Senyawa-senyawa pengobatan
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
NO983217L (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider